Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Federal Trade Commission
Argus Health
Accenture
Covington
Medtronic
Harvard Business School
Chubb

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040360

« Back to Dashboard

NDA 040360 describes PERPHENAZINE, which is a drug marketed by Pharm Assoc, Ani Pharms Inc, Mylan Pharms Inc, Sandoz, Vintage Pharms, Watson Labs Inc, Wilshire Pharms Inc, Fosun Pharma, Ivax Sub Teva Pharms, Mylan, Par Pharm, Sun Pharm Industries, and Watson Labs, and is included in forty-five NDAs. It is available from fifteen suppliers. Additional details are available on the PERPHENAZINE profile page.

The generic ingredient in PERPHENAZINE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
Summary for 040360
Tradename:PERPHENAZINE
Applicant:Pharm Assoc
Ingredient:perphenazine
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 040360

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CONCENTRATE;ORALStrength16MG/5ML
Approval Date:May 25, 2001TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Department of Justice
Dow
Fuji
Federal Trade Commission
Express Scripts
Covington
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.